Qualitest Lisinopril 40mg Recall: Failed Dissolution
Qualitest recalls specific lots of Lisinopril Tablets, USP 40 mg due to failed dissolution specifications. Check your bottle's NDC and lot number.
Use caution until it’s fixed
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Qualitest Pharmaceuticals is recalling specific lots of Lisinopril Tablets, USP, 40 mg because they failed dissolution specifications. This means the tablets may not release the medication properly in the body. The recall affects 8,705 bottles distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/43872-vintage-pharmaceuticals-llc-dba-qualitest-pharmaceuticals-recalls-lisinopril-tablets-usp.
Source Summary by GovInfoNow · govinfonow.com/recall/43872-vintage-pharmaceuticals-llc-dba-qualitest-pharmaceuticals-recalls-lisinopril-tablets-usp · Updated October 12, 2026 · FDA enforcement record: FDA #D-1406-2015
Cite this page
“Qualitest Lisinopril 40mg Recall: Failed Dissolution.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43872-vintage-pharmaceuticals-llc-dba-qualitest-pharmaceuticals-recalls-lisinopril-tablets-usp. Based on FDA recall #D-1406-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1406-2015%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, which is a quality control test ensuring the drug breaks down correctly. If the medication does not dissolve as intended, patients may not receive the full therapeutic dose, potentially leading to inadequate treatment of their condition.
Who’s affected
Patients prescribed Lisinopril 40 mg who purchased bottles from Qualitest Pharmaceuticals between the manufacturing dates and expiration date of February 2017. Individuals relying on this specific dosage for blood pressure or heart conditions are most at risk.
How to tell if you have this one
Check your bottle for NDC 0603-4214-60 (45-count) or NDC 0603-4214-28 (500-count). Verify the lot number is either C0570215B or C0570215A and the expiration date is 02/17. The product was manufactured for Qualitest Pharmaceuticals in Huntsville, AL.
- Brand
Qualitest Pharmaceuticals- Category
Drug
What to do — step by step
Check your medication bottle
Verify if your Lisinopril Tablets, USP 40 mg match the recalled NDCs (0603-4214-60 or 0603-4214-28) and lot numbers (C0570215B or C0570215A).
Contact your pharmacist or doctor
If you have the recalled product, consult your healthcare provider for instructions on whether to return it or get a replacement.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Qualitest Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1406-2015 (July 29, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1406-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.